Brief: Envoy Medical Receives FDA Approval To Advance Its Clinical Trial To Final Stage
07/10/2025 16:39
Oct 7 (Reuters) - Envoy Medical Inc COCH.O: ENVOY MEDICAL: RECEIVES FDA APPROVAL TO ADVANCE ITS PIVOTAL CLINICAL TRIAL TO FINAL STAGE BASED ON SUBMISSION OF PROMISING THREE-MONTH DATA ENVOY MEDICAL INC - EXPECTS FULL ENROLLMENT BY EARLY 2026 - SEC FILING ENVOY MEDICAL INC -MOVING ITS TIMELINES UP THREE TO SIX MONTHS, CUTTING ITS ANTICIPATED CAPITAL NEED BY $10-$15 MILLION Source text: [ID:n0001213900-25-096845] Further company coverage: COCH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Envoy Medical
See all newsEnvoy expects U.S.-Turkey to 'soon' solve issue of sanctions over S-400 defences
Brief: Envoy Medical Receives FDA Approval To Advance Its Clinical Trial To Final Stage
Brief: Envoy Medical Enters Satisfaction Agreement With GAT Funding On Aug 25 - SEC Filing
Brief: Envoy Medical Appoints Robert Potashnick As Interim CFO
Brief: Envoy Medical Inc - Secures $10 Million Financing From Glen Taylor